GSK

Ultime notizie

Titoli nella lingua originale della fonte.

• NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company? (si apre in una nuova scheda)

  Stocktwits · 1 ott 2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (si apre in una nuova scheda)

  Stock Titan · 1 ott 2026

• GSK adds liver candidate from Wave RNA partnership (si apre in una nuova scheda)

  European Biotechnology Magazine · 1 ott 2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (si apre in una nuova scheda)

  BioBuzz · 1 ott 2026

• GSK Stockmann advises Target Global on Health Force investment (si apre in una nuova scheda)

  ICLG · 1 ott 2026

• GSK slides Wednesday, underperforms market (si apre in una nuova scheda)

  MarketWatch · 30 set 2026

• GSK Taps Wave Life Sciences’ siRNA Program, Triggering $12M Milestone Payment (si apre in una nuova scheda)

  Genome Web · 30 set 2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (si apre in una nuova scheda)

  Fierce Biotech · 30 set 2026

• Wave to receive $12M milestone from GSK (WVE:NASDAQ) (si apre in una nuova scheda)

  Seeking Alpha · 30 set 2026

• Wave Life Sciences Announces GSK Advances Hepatology Candidate from SpiNA siRNA Collaboration (si apre in una nuova scheda)

  Quiver Quantitative · 30 set 2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (si apre in una nuova scheda)

  globenewswire.com · 30 set 2026

• GSK selected a liver candidate for development, triggering $12 million for Wave. (si apre in una nuova scheda)

  Stock Titan · 30 set 2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (si apre in una nuova scheda)

  Yahoo Finance · 30 set 2026

• 5 minutes with Tia Vincent, GSK (si apre in una nuova scheda)

  European Medical Journal · 29 set 2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (si apre in una nuova scheda)

  firstwordpharma.com · 29 set 2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (si apre in una nuova scheda)

  Proactive financial news · 29 set 2026

• Gates Foundation Extends Funding for AN2 Therapeutics, GSK Research Collab (si apre in una nuova scheda)

  Contract Pharma · 28 set 2026

• AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK (si apre in una nuova scheda)

  Business Wire · 28 set 2026

• GSK PLC | British Pharmaceutical & Biotechnology Company (si apre in una nuova scheda)

  Britannica · 26 set 2026

• Emma Walmsley | Former GSK CEO & British Business Executive (si apre in una nuova scheda)

  Britannica · 26 set 2026

• GSK reprimanded for lack of transparency in vaccine campaign case (si apre in una nuova scheda)

  medwatch.com · 25 set 2026

• How splitting from GSK taught Haleon a spin-off is not a finish line (si apre in una nuova scheda)

  Semafor · 25 set 2026

• GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger? (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior (si apre in una nuova scheda)

  Fierce Pharma · 24 set 2026

• At a listed price of $50.72, GSK (NYSE: GSK) president acquires 9.414 notional shares in her savings plan (si apre in una nuova scheda)

  Stock Titan · 24 set 2026

• GSK's Jemperli (dostarlimab) accepted for review by Health Canada for patients with dMMR/MSI-H locally advanced rectal cancer (si apre in una nuova scheda)

  BioSpace · 24 set 2026

• Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• $3.3 Million in New Philanthropic Commitments for Good Jobs Western North Carolina From The Rockefeller Foundation, John M. Belk Endowment, and NC GSK Foundation (si apre in una nuova scheda)

  The Rockefeller Foundation · 24 set 2026

• GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care (si apre in una nuova scheda)

  es.tradingview.com · 23 set 2026